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A B S T R A C T
Aim. Squamous cell carcinoma of the penis (PC) has traditionally been treated with partial penectomy with a
2-cm margin. More conservative resection margins have been reported to have no effect on oncologic control,
but there is no consensus in the literature regarding functional outcomes after organ-preserving surgery
for PC.
Methods. Six patients meeting inclusion criteria were retrospectively identiﬁed to have received organ-sparing
surgery for PC at the Cleveland Clinic from 2003 to 2012. Patient’s sexual and urinary quality of life was assessed
retrospectively using the International Index of Erectile Function and the patient-reported outcome measure for
urethral stricture surgery.
Results. Three patients (50%) report normal erections but describe intercourse as not very enjoyable and report
being dissatisﬁed with their sex life. The remaining 50% consistently report no sexual activity and denied feeling
sexual desire. All report only mild urinary symptoms, including decreased stream (18%) and feelings of incomplete
voiding (67%). Eighty-three percent of patients report their sexual symptoms do not interfere with their daily lives.
One hundred percent report being satisﬁed with their procedure.
Conclusion. Our study is the ﬁrst to use standardized, validated questionnaires to evaluate sexual and urinary
function in a North American penile cancer patient population. We report excellent overall urinary function and
quality of life following penile-sparing surgery for PC, and our results depict more realistic sexual outcomes than
those reported in studies using non-blinded and non-validated methods. Scarberry K, Angermeier KW,
Montague D, Campbell S, and Wood HM. Outcomes for organ-preserving surgery for penile cancer. Sex
Med 2015;3:62–66.
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Introduction
Squamous cell carcinoma of the penis (PC) is arare cancer with an incidence of <1 in 100,000
men in North America and Europe [1]. Local
control of invasive PC has traditionally been
achieved with partial penectomy with a 2-cm
margin, but recent literature shows more conserva-
tive resection margins have no effect on long-term
oncologic control with the potential to further pre-
serve acceptable sexual and urinary function [2–4].
While various studies have reported on functional
outcomes after organ-preserving surgeries includ-
ing glansectomy (removal of the glans) or distal
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corporectomy (removal of glans and <2-cm margin
of distal corpora cavernosa), few have utilized a
validated questionnaire to assess postoperative out-
comes. Our objective was to investigate patient
satisfaction with their sexual and urinary outcomes
following organ-preserving surgery, including
glansectomy or distal corporectomy, for carcinoma
of the penis.
Patients
Fifty living patients were retrospectively identiﬁed
by searching hospital billing codes for procedures
“penectomy” or “partial penectomy” performed
between 2003 and 2012 at the Cleveland Clinic
Glickman Urological Institute. Upon chart review,
25 patients were excluded as they had undergone
surgery for a diagnosis other than PC. Ten
required complete penectomy and were excluded
from the study. Eight patients were lost to
follow-up or unable to be contacted, and one
refused participation in the study. All six remaining
patients were conﬁrmed to have undergone
penile-sparing surgery on chart review, reported
their general health as good or very good, and
were included in the study.
Methods
Approval was obtained by the Cleveland Clinic
Institutional Review Board, and consent was
obtained via telephone. Patients were asked to
complete two questionnaires addressing their
health and quality of life (QOL) and return the
results by mail. The International Index of Erectile
Function (IIEF-15) was utilized as a validated
questionnaire to assess erectile function and satis-
faction with sexual activity, and results were used
to calculate a speciﬁc score for each patient regard-
ing each of the four domains of sexual function
represented on the IIEF [5].
The patient-reported outcome measure
(PROM) for urethral stricture surgery, as reported
by Jackson et al., was utilized as a validated ques-
tionnaire to quantify changes in voiding symptoms
and health-related QOL following penile surgery
[6]. The survey included 22 questions addressing
urinary symptoms, sexual function, and percep-
tions of overall health and satisfaction with the
operation.
Sociodemographic data and operation details
were obtained through chart review and were
codiﬁed and arranged in tables with questionnaire
results. Patients were provided with a $25 Amazon
.com gift card as compensation.
Results
Six patients completed questionnaires. The mean
(range) follow-up period from initial surgery to
present investigation was 52 ± 16 (25–84) months,
and the mean (range) current age is 67 ± 10 (56–
87) years old.
Two patients had undergone a glansectomy and
glanuloplasty with split-thickness skin ﬂap for cov-
erage of the tips of the corporal bodies. Four
patients required proximal dissection and distal
corporectomy, with incision lines at 3, 5, 8, and
10 mm proximal to the coronal sulcus, respec-
tively. Operations were performed by three sur-
geons. Squamous cell carcinoma with negative
surgical margins was conﬁrmed on ﬁnal pathology
for all cases. Four patients required radical or
modiﬁed inguinal lymphadenectomy.
Sexual Function (Tables 1 and 2)
Three patients (50%) reported erections with
normal rigidity. All three report low or moderate
sexual desire. Two (33%) reported sexual activity
with successful penetration, orgasm, and ejacula-
tion at least a few times. Both of these patients
report dissatisfaction overall with respect to sexual
QOL.
The remaining three patients consistently
report no sexual activity or attempts at intercourse
with severely or moderately reduced rigidity of
erections and no sexual desire.
Five (83%) patients report their sexual symp-
toms do not at all interfere with their daily lives.
Urinary Function (Table 3)
No patients report any episodes of cystitis. Four
(67%) report normal strength of urinary stream,
with only one reporting a consistent reduction in
strength. Three (50%) report occasional wetness
in their pants a few minutes after urinating. Four
patients report occasionally feeling they have not
fully emptied their bladder after urinary.
Five (83%) patients report their urinary symp-
toms do not at all interfere with their daily lives.
Satisfaction
All patients report their overall health as being
“good” or “very good” and report being “satisﬁed”
or “very satisﬁed” with the outcome of their
procedure.
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Discussion
Penile cancer is most common in Asian, African,
and South American countries where it accounts
for up to 10% of cancers in men [1]. Poor hygiene
is a risk factor most commonly associated with
penile carcinoma, and high rates of early male
circumcision likely explain low rates of PC in the
United States. The infrequency with which PC is
seen in Western, circumcised males has made it
difﬁcult to acquire data for studies addressing basic
questions patients may have regarding postopera-
tive sexual and urinary outcomes. Our study is the
ﬁrst to use standardized, validated questionnaires
to evaluate sexual and urinary function in a U.S.
patient population [7]. Patients were overall recep-
tive to both the IIEF and PROM for urethral
stricture questionnaires, with six patients matching
study criteria consenting to the study and complet-
ing both questionnaires.
Maintenance of adequate sexual function is a
very common concern for men undergoing treat-
ment for penile cancer. It has been previously
shown that seven of 25 men treated for penile
cancer by various methods reported that, if asked
again, they would choose a treatment with lower
long-term survival to increase the chance of
remaining sexually potent [8].
Historically, the goal of treatment for penile
carcinoma is complete excision with adequate
margins, and organ-sparing surgical options such
as those described in this study have great poten-
tial for allowing men with PC to retain sexual
potency. Other conservative treatment modalities
including radiotherapy, Mohs micrographic
surgery, and laser therapy are increasingly being
used. Initial studies have shown these modalities
to have improved sexual health outcomes over
partial penectomy with potential for comparable
oncologic outcomes, particularly in early stage
disease [2,9,10]. The lack of outcomes data and
non-standardized outcomes reporting for both
newer surgical approaches and alternative therapy
modalities hinders the ability of cancer patients
to make treatment decisions.
In our present study, we showed that U.S. PC
patients who underwent glansectomy and/or distal
corporectomy had relatively poor erectile health
and function after treatment, with 50% reporting
poor erection quality and 67% reporting no sexual
activity. Despite poor sexual health outcomes, no
patients reported a signiﬁcant negative effect on
their procedure satisfaction or QOL, suggesting
maintaining sexual function may not be primarilyTa
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important to all men undergoing penile cancer
surgery.
Our results are in disagreement with two
studies from Europe, in which 100% of a com-
bined 32 PC patients receiving glansectomy or
distal corporectomy with reconstruction reported
adequate postoperative sexual function [11,12].
However, these studies did not use validated ques-
tionnaires in their postoperative data collection
and did not collect data in a blinded fashion.
Our results were comparable with a third
single-institution study from the United Kingdom
in which ﬁve of 11 (45%) patients reported no
sexual activity and two (18%) reported inability to
obtain an erection on postoperative questionnaires
following glansectomy with skin grafting [13]. The
degree of sexual and erectile dysfunction following
PC surgery is expected to be higher than an age-
matched equivalent group without a history of
penile surgery, which is reported as a 17–34% rate
of moderate erectile dysfunction of similar age
[14]. The rates of sexual dysfunction reported with
the use of a validated questionnaire here and in
O’Kane et al. ﬁt more closely with expectations
than rates reported without the use of a question-
naire [13].
Voiding symptoms reported here were gener-
ally very mild, with no cystitis, incontinence, or
severe decreases in stream strength reported.
Additionally, no patients reported an effect on
their QOL based on urinary symptoms following
the procedure. The few studies addressing urinary
outcomes reported similarly positive results,
including all of 179 patients in Philippou et al.
reporting successful upright voiding, suggesting
organ-sparing surgery for PC may not pose a sig-
niﬁcant risk for urinary dysfunction [2].
Our conclusions are limited by the very small
patient number meeting selection criteria and lack
of a control, which could allow for thorough com-
parison and statistical analysis of many penile
cancer treatments.
In conclusion, our study supports excellent
overallQOLand urinaryQOLafter penile-sparing
operations for PC. However, sexual function and
desire are poorer, with 50% of respondents report-
ing no sexual function or desire. Curiously, sexual
function outcomes did not seem to bear on per-
ceived overall QOL for these men. Finally, the
limited reports in this area and wide variability of
cultural differences with respect to circumcision
call for multi-institutional, cross-cultural trials
using validated questionnaires.
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